Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BridgeBio Pharma (BBIO) Shares Outstanding (Weighted Average) (2019 - 2025)

BridgeBio Pharma (BBIO) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $191.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 2.93% to $191.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $191.5 million through Dec 2025, up 2.93% year-over-year, with the annual reading at $191.5 million for FY2025, 2.93% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $191.5 million in Q4 2025 for BridgeBio Pharma, roughly flat from $191.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $191.9 million in Q3 2025 to a low of $138.6 million in Q1 2021.
  • Historically, Shares Outstanding (Weighted Average) has averaged $164.6 million across 5 years, with a median of $157.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 25.0% in 2021 and later fell 0.32% in 2022.
  • Year by year, Shares Outstanding (Weighted Average) stood at $144.4 million in 2021, then grew by 2.16% to $147.5 million in 2022, then rose by 10.39% to $162.8 million in 2023, then rose by 14.3% to $186.1 million in 2024, then grew by 2.93% to $191.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BBIO at $191.5 million in Q4 2025, $191.9 million in Q3 2025, and $190.5 million in Q2 2025.